A new blood test has diagnosed heart attacks faster in a clinical study performed at the University of Texas Southwestern Medical Center.

The blood test features high sensitivity for cardiac troponin, and is intended to determine if a person is having a heart attack upon arriving in the emergency room.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

During the study, the test was observed to be safe and effective. Its efficacy was compared to a standard method that requires three hours to complete.

“The blood test features high sensitivity for cardiac troponin, and is intended to determine if a person is having a heart attack upon arriving in the emergency room.”

University of Texas Southwestern Medical Center cardiologist Rebecca Vigen said: “We did not miss any heart attacks using this test in this population.

“The test also allowed us to determine faster that many patients who had symptoms of a heart attack were not having a heart attack than if we had relied on the traditional test.”

The research study involved a total of 536 patients who were admitted to an emergency room with heart attack symptoms such as chest pains and shortness of breath.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

A procedure developed by the university’s team was used to evaluate results obtained using the new test. Data showed that the test could successfully rule out heart attack in 30% of patients instantly and another 25% at one hour.

At three hours, the new approach was able to rule out 83.8% of patients compared to 80.4% in the case of the traditional test.

Vigen added: “We anticipate that this procedure will allow many patients with chest pain to be given a ‘yes’ or ‘no’ diagnosis of whether they are having a heart attack faster.”

Results from the research were published in the American Heart Association’s Circulation journal.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact